Related Experiment Video

Updated: Aug 6, 2026

Noninvasive Sampling of Mucosal Lining Fluid for the Quantification of In Vivo Upper Airway Immune-mediator Levels
05:31

Noninvasive Sampling of Mucosal Lining Fluid for the Quantification of In Vivo Upper Airway Immune-mediator Levels

Published on: August 7, 2017

Airway inflammation in childhood asthma

Angelo Barbato1, Graziella Turato, Simonetta Baraldo

  • 1Department of Pediatrics, University of Modena and Reggio Emilia, Italy.

American Journal of Respiratory and Critical Care Medicine
|August 2, 2003
PubMed

Insights

Pediatric asthma shows airway eosinophilia and basement membrane thickening, similar to adults. Children with asthma also exhibit reduced transforming growth factor-beta type II receptor (TGFbeta-RII) expression.

Area of Science:

  • Pediatric Pulmonology
  • Respiratory Medicine
  • Cellular Pathology

Background:

  • Asthma pathology is well-documented in adults, but less understood in pediatric populations.
  • Bronchial biopsies in childhood asthma are infrequently studied.
  • Understanding early airway changes is crucial for timely intervention.

Purpose of the Study:

  • To investigate and characterize airway pathology in children with mild/moderate asthma.
  • To compare airway inflammation markers between asthmatic children, atopic children, and healthy controls.
  • To explore the role of transforming growth factor-beta1 (TGF-beta1) signaling in pediatric asthma.

Main Methods:

  • Analysis of bronchial biopsies from 23 children (9 mild/moderate asthma, 6 atopy, 8 controls).
  • Quantification of basement membrane thickness, eosinophils, mast cells, neutrophils, macrophages, and T lymphocytes.
  • Measurement of transforming growth factor-beta1 (TGF-beta1) and its receptors (TGFbeta-RI, TGFbeta-RII) expression in subepithelium.

Main Results:

  • Children with asthma showed increased basement membrane thickness and eosinophils compared to controls.
  • These changes were also observed in children with atopy but no asthma, suggesting early inflammatory processes.
  • Asthmatic children exhibited decreased TGFbeta-RII expression, which correlated negatively with eosinophil counts and positively with symptom duration.

Conclusions:

  • Airway eosinophilia and basement membrane thickening are present even in mild childhood asthma and atopy.
  • Reduced TGFbeta-RII expression is a specific finding in pediatric asthma, distinct from atopy alone.
  • These findings highlight early pathological changes in pediatric asthma and potential therapeutic targets.

More Related Videos

Methodology for Sputum Induction and Laboratory Processing13:28

Methodology for Sputum Induction and Laboratory Processing

Published on: December 17, 2017

Advanced Imaging of Lung Homing Human Lymphocytes in an Experimental In Vivo Model of Allergic Inflammation Based on Light-sheet Microscopy10:39

Advanced Imaging of Lung Homing Human Lymphocytes in an Experimental In Vivo Model of Allergic Inflammation Based on Light-sheet Microscopy

Published on: April 16, 2019

Related Concept Videos

Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Asthma I: Introduction01:28

Asthma I: Introduction

Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
Asthma III: Clinical Manifestations01:13

Asthma III: Clinical Manifestations

Asthma presents with a characteristic pattern of episodic respiratory symptoms that reflect underlying airway inflammation, bronchoconstriction, and mucus hypersecretion. Although severity varies among individuals, certain clinical manifestations are considered hallmarks of the disorder and often guide diagnosis and assessment.Respiratory SymptomsA persistent cough is one of the most common early features of asthma. It is frequently dry and tends to worsen at night or in the early morning,...
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...